Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
about
bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapyMicrotubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosisApoptosis: targets in pancreatic cancerCombination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteinsAltered methional homoeostasis is associated with decreased apoptosis in BAF3 bcl2 murine lymphoid cellsSynergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell linesCcdc94 protects cells from ionizing radiation by inhibiting the expression of p53The use of therapeutic peptides to target and to kill cancer cells.Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac.Histone H4 acetylation dynamics determined by stable isotope labeling with amino acids in cell culture and mass spectrometry.Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases.Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity.Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitroEGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cellsIonizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression.Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiationOverexpression of Dickkopf-3 induces apoptosis through mitochondrial pathway in human colon cancerCombination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukemic cells.Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.In vivo imaging with oligonucleotides for diagnosis and drug development.Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.Markers of apoptosis in stage IB squamous cervical carcinoma.Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells.Improving the therapeutic potential of endostatin by fusing it with the BAX BH3 death domain.Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model.Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells.Bcl-2 protein expression and long-term survival in breast cancerNetwork analysis of an in vitro model of androgen-resistance in prostate cancer.Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells.Prognostic value of bcl-2 expression in invasive breast cancer.Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoproteinp53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study
P2860
Q24319116-2784D266-A8EC-4CCF-9EF4-44709272EBB3Q24551023-A9C248EA-2513-484A-A697-D4D46F79E08AQ24551055-F13A1E4D-7FF4-4DA3-9400-171F518D1A6FQ24609324-B92785B9-16FD-4767-BB62-92E223AFB822Q24800170-6CE9530D-7CB8-41FE-82F7-FD598B7B6B57Q28368394-984630F3-6D61-4B2E-84F1-68656F977F6DQ28369128-B4EC1089-4AFC-4490-AA58-C1FBF4E7F634Q28378813-0EB1292F-55FB-4E97-92AE-2BCA494F5BEBQ28469349-A702FA49-0040-4A3A-9592-514F0B680FE2Q28483080-A6C9A96A-D0E6-40F9-A1E0-CCF069421E1CQ30418414-ACF05B0A-3958-4924-BE62-BB6FB739CA9AQ31156666-8DA6F92E-6D11-44AD-A66D-74A6FC6C12EDQ33272682-D2F4EB54-8EFD-4093-8550-651A7E8A0C9AQ33485242-0C989D91-3827-4C26-B9B7-ED623B48789EQ33608788-CB63A0A0-8BEC-4F37-A318-7306511F95C9Q33673430-EB699DF8-E192-4B80-8F4B-E7293A9C2807Q33744180-462BC1D4-95F3-46C7-97EF-613DB97D6193Q33793142-C3ED460A-8C1A-40EE-9F65-DA680A57D3DDQ33808800-B22ABE07-8625-47A4-A787-11B4BC5787C5Q33924886-5C06259A-640B-42F4-B161-A39474CBA5C7Q34197959-FB4616EA-BC38-4207-9818-78AF6CBF4011Q34223630-E0A4344D-AA54-42C7-B46F-448BFE703298Q34243489-60DC0161-9C15-4763-8065-1A1A8109CB8FQ34465240-4C2DD290-371B-49AF-8AD1-03D0D6CE7D7CQ34490725-1799690C-13CA-4B47-A314-2ACAB37E56E2Q35067605-E1928943-9E91-4A54-AC0A-11EAEAE58399Q35127223-C127055C-A523-4FE4-9059-883E0CD1B3CFQ35128216-5FF9C223-FA7E-4B9E-90B8-6C0894359D07Q35588600-664ADE39-FC58-4F66-B510-AEC9EA8BB32DQ35670634-B18827E6-F71B-41D5-9427-3AD220EDFDBEQ35679496-DD8E3026-22E2-4147-9997-497176C3D21CQ35788016-C7D53289-700F-4DBF-9960-6790596BF754Q35796201-AC8F3933-6DDF-44A5-9768-EB1D605423B9Q35834034-746BF1C4-6EC9-4D95-AFEF-BBB049A8B57CQ35836735-E84CD917-7A21-4A0D-B51D-FC14A5AFB43EQ35847722-79BB408B-C11C-484C-B440-5F41A3253199Q35938280-93B1E834-2DEB-41C9-8642-1688FD8E8401Q36081445-B460A393-AD16-42A4-B566-54FF9147091FQ36115251-F2417E33-9A81-4268-9200-B1C54C7EEC61Q36115950-66E301DC-B19C-4B21-99AC-8279F3BD5EC6
P2860
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@ast
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@en
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@nl
type
label
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@ast
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@en
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@nl
prefLabel
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@ast
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@en
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.
@nl
P1433
P1476
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
@en
P2093
P304
P407
P577
1993-01-01T00:00:00Z